De Novo Classification
Process (Evaluation of Automatic Class III Designation)
Revision of a currently approved collection
No
Regular
12/02/2021
Requested
Previously Approved
36 Months From Approved
08/31/2022
73
185
12,377
10,730
5
7,283
The ICR describes the information
collection involved with the De Novo classification process for
medical devices. FDA uses the information in the De Novo request to
evaluate whether the medical device may be reclassified from Class
III to Class I or II, and if applicable, to determine the general
and/or special controls necessary to sufficiently regulate the
medical device. Respondents to the information collection are
medical device manufacturers.
US Code:
21
USC 513 Name of Law: The FD&C Act; Classification of
Devices Intended for Human Use
US Code: 21 USC 360c Name of Law:
Classification of Devices Intended for Human Use
The information collection
includes program changes and adjustments. Consistent with estimates
found in our analysis of impacts for RIN 0910-AH53, we have
increased our estimate of the total number of respondents since
last OMB review and approval. Also, the burden we previously
attributed to guidance instruction regarding De Novo classification
requests and withdrawals, we now attribute to requirements found in
agency regulations. However, in our estimated burden per response
for a De Novo request, we continue to account for burden that may
be associated with completion of the Acceptance Checklist. Finally,
we have corrected an inadvertent error found in our proposed
rulemaking. Cumulatively, these changes and adjustments result in
an overall annual increase of burden by 1,647 hours and decrease of
responses by 112.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.